📰 Mochida News
Page 5 - Mochida News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mochida. Real-time updates on events, politics, business and more.
February 4, 2021
Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for 2020 - a successful year marked by outstanding clinical data Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year 2020. Business highlights Positive results in the Phase 3 program of daridorexant, demonstrating improved overall sleep and daytime functioning of patients with insomnia Daridorexant new drug application (NDA) submitted to the US FDA on January 8, 2021 Positive results in the Japanese reg...
February 4, 2021
131.2 US GAAP revenue of CHF 72 million in 2020 consisted of contract revenue recognized in connection with the collaboration agreements with Neurocrine Biosciences, Inc. (CHF 50 million), Janssen Biotech, Inc. (CHF 11 million), Roche (CHF 6 million), Mochida Pharmaceutical Co., Ltd (CHF 3 million) and Santhera Pharmaceuticals Ltd (CHF 2 million) compared to a revenue of CHF 24 million in 2019. US GAAP operating expenses in 2020 amounted to CHF 482 million (CHF 506 million in 2019), of which CH...
February 4, 2021
Summary of the Report Growth of the Pancreatitis Drugs market is due to the increasing consumers awareness, high demand and ongoing research and development. These are the major factors that has boosted the market growth at present and is expected to do so during the estimated period as well. There are other factors too that are further supporting the growth of this market. To avail Sample Copy of the report @ Segmentation and Scope of the Pancreatitis Drugs Market The Pancreatitis Drugs mark...